Risk factors for Human Papillomavirus Exposure and Co-factors for Cervical Cancer in Latin America and the Caribbean

被引:95
作者
Almonte, Maribel [1 ,2 ]
Albero, Ginesa [3 ]
Molano, Monica [4 ]
Carcamo, Cesar [5 ]
Garcia, Patricia J. [5 ,6 ]
Perez, Gonzalo [7 ]
机构
[1] London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1, England
[2] Wolfson Inst Prevent Med, Canc Res UK Ctr Epidemiol Math & Stat, London, England
[3] Hosp Llobregat, ICO, CERP, UNIC, Barcelona, Spain
[4] Inst Nacl Cancerol, Grp Invest Biol Canc, Bogota, Colombia
[5] Univ Peruana Cayetano Heredia, Lima, Peru
[6] Peruvian Natl Inst Hlth, Lima, Peru
[7] Univ Rosario, Grp Saludcoop, Natl Res Ctr, Bogota, Colombia
关键词
HPV; Cervical cancer; Risk factors; Latin America; Caribbean; Sexual behaviour; Male sexual behaviour; HPV variants;
D O I
10.1016/j.vaccine.2008.06.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The incidence of cervical cancer in Latin America and the Caribbean (LAC) is among the highest in the world. Because there are major demographic shifts happening in LAC countries (population growth, urbanization and ageing) cervical cancer incidence and mortality will likely continue to be a significant public health problem. Overall human papillomavirus (HPV) prevalence in the LAC general population has been found to be 2-fold higher than the average worldwide prevalence. The large HPV and cancer burden may be explained by the highly prevalent HPV variants of HPV types -16 and 18, which have an increased oncogenic potential. Given the major mode of transmission of genital HPV is sexual, certain, patterns of sexual behaviour (early age at first sexual intercourse, number of sexual partners and sexual behaviour of the partner) are associated with an increased risk of HPV genital acquisition. Although HPV infection is necessary for carcinogenesis, certain co-factors (high parity. long term use of oral contraceptives, smoking and co-infection with the human immunodeficiency virus (HIV)) help in the progression from infection to cancer. Many studies that have contributed to this evidence have been carried out in LAC and are reviewed and summarised in this article. Since HPV vaccines will likely take years to implement, and many more years to show impact on disease, cervical cancer screening programmes remain as the key intervention to control disease in LAC in the years to come. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:L16 / L36
页数:21
相关论文
共 82 条
  • [1] Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru
    Almonte, Maribel
    Ferreccio, Catterina
    Winkler, Jennifer L.
    Cuzick, Jack
    Tsu, Vivien
    Robles, Sylvia
    Takahashi, Rina
    Sasieni, Peter
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (04) : 796 - 802
  • [2] [Anonymous], AIDS EP UPD DEC 2007
  • [3] Cervical carcinoma and reproductive factors:: Collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies
    Appleby, P.
    Beral, V.
    de Gonzalez, A. Berrington
    Colin, D.
    Franceschi, S.
    Green, J.
    La Vecchia, C.
    Peto, J.
    Plummer, M.
    Randi, G.
    Sweetland, S.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (05) : 1108 - 1124
  • [4] Appleby P, 2007, LANCET, V370, P1609, DOI 10.1016/S0140-6736(07)61684-5
  • [5] Asian-American variants of human papillomavirus 16 and risk for cervical cancer:: a case-control study
    Berumen, J
    Ordoñez, RM
    Lazcano, E
    Salmeron, J
    Galvan, SC
    Estrada, RA
    Yunes, E
    Garcia-Carranca, A
    Madrigal-de la Campa, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (17): : 1325 - 1330
  • [6] THE MALE FACTOR IN THE ETIOLOGY OF CERVICAL-CANCER AMONG SEXUALLY MONOGAMOUS WOMEN
    BRINTON, LA
    REEVES, WC
    BRENES, MM
    HERRERO, R
    GAITAN, E
    TENORIO, F
    DEBRITTON, RC
    GARCIA, M
    RAWLS, WE
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (02) : 199 - 203
  • [7] Epidemiology and transmission dynamics of genital HPV infection
    Burchell, Ann N.
    Winer, Rachel L.
    de Sanjose, Silvia
    Franco, Eduardo L.
    [J]. VACCINE, 2006, 24 : 52 - 61
  • [8] Burk RD, 2003, CANCER RES, V63, P7215
  • [9] Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants
    Calleja-Macias, IE
    Kalantari, M
    Huh, J
    Ortiz-Lopez, R
    Rojas-Martinez, A
    Gonzalez-Guerrero, JF
    Williamson, AL
    Hagmar, B
    Wiley, DJ
    Villarreal, L
    Bernard, HU
    Barrera-Saldaña, HA
    [J]. VIROLOGY, 2004, 319 (02) : 315 - 323
  • [10] Campos RR, 2005, REV BRAS GINECOL OBS, V27, P248, DOI 10.1590/S0100-72032005000500004